Review Article
Mesenchymal Stem Cells in Immune-Mediated Bone Marrow Failure Syndromes
Table 3
Summary of BM MSC characteristics in MDS, acquired AA, and CIN patients.
| ā | MDS | Acquired AA | CIN |
| Immunophenotype | Normal | Normal | Normal | Cell morphology | Aberrant | Aberrant | N.D. | Cell growth | Defective | Defective | Defective | Senescence | Increased | N.D. | N.D. | Multipotency | Defective () | Defective | Normal | Genomic profile | Frequent genetic aberrations, unrelated to HSC abnormalities | Aberrant gene expression profile | N.D. | Methylation profile | Altered | N.D. | N.D. | Immune properties | Impaired mainly in low-risk MDS | Impaired () | Normal | Haemopoietic support capacity | Impaired () | N.D. | N.D. |
|
|
A question mark () indicates that existing data are still inconclusive or contradictory, and N.D. indicates the lack of associated data.
|